| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
|
Maciocia, Paul M.
|
|
|
140 |
1 |
p. 25-37
|
artikel
|
| 2 |
Approval of brexucabtagene autoleucel for adults with relapsed and refractory acute lymphocytic leukemia
|
Frey, Noelle V.
|
|
|
140 |
1 |
p. 11-15
|
artikel
|
| 3 |
A unique report of breast intravascular NK/T-cell lymphoma mimicking breast carcinoma
|
Zhou, Luting
|
|
|
140 |
1 |
p. 78
|
artikel
|
| 4 |
Avoiding fratricide: a T-ALL order
|
Gower, Mark
|
|
|
140 |
1 |
p. 3-4
|
artikel
|
| 5 |
CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
|
Bueno, Clara
|
|
|
140 |
1 |
p. 38-44
|
artikel
|
| 6 |
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL
|
Müller, Kristina
|
|
|
140 |
1 |
p. 45-57
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
140 |
1 |
p. i
|
artikel
|
| 8 |
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs
|
Steffin, David H.M.
|
|
|
140 |
1 |
p. 16-24
|
artikel
|
| 9 |
Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
|
Kanack, Adam J.
|
|
|
140 |
1 |
p. 73-77
|
artikel
|
| 10 |
Please eat me! Targeting CD47 and CD38 in T-ALL
|
Diorio, Caroline
|
|
|
140 |
1 |
p. 6-8
|
artikel
|
| 11 |
Revealing the dark secrets of TP53-mutated AML
|
Hasserjian, Robert P.
|
|
|
140 |
1 |
p. 8-10
|
artikel
|
| 12 |
Safety of genetically modified T cells
|
Maus, Marcela V.
|
|
|
140 |
1 |
p. 1-2
|
artikel
|
| 13 |
The CD19neg needle in the haystack
|
Shah, Nirali N.
|
|
|
140 |
1 |
p. 4-6
|
artikel
|
| 14 |
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia
|
Tashakori, Mehrnoosh
|
|
|
140 |
1 |
p. 58-72
|
artikel
|
Tijdschrift beschrijving